The present study aimed to review current approaches and advances in the treatment of hemangiomas. Hemangiomas account for approximately 45.7% of all benign tumors in children, with up to one-quarter of newborns affected. The challenges in diagnosing and managing hemangiomas are compounded by the lack of a standardized classification system, which hinders effective communication among pediatricians, dermatologists, pediatric surgeons, and oncologists. One of the key issues in treatment remains the determination of clear indications for initiating therapy. Ulcerated hemangiomas, especially those complicated by infection and hemorrhage, pose a significant clinical concern. Patient management strategies must be individualized, with propranolol therapy and laser ablation recognized as the most effective, safe, and cosmetically favorable options. In addition, surgical excision and electrocoagulation have shown durable, relapse-free outcomes. This study involves a statistical analysis of 40 pediatric case records, presenting findings on the distribution of the disease by sex, age, anatomical location, and treatment modalities used.
